| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Lixte Biotechnology Holdings, Inc. (LIXT) has 10 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. LIXT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 350.0K | $1.07M | - | |
| CFO | 50.0K | $153.3K | - | |
| Dir | 25.0K | $76.6K | - | |
| Dir | 25.0K | $76.6K | - | |
| Dir | 25.0K | $76.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 30, 2020 | Forman Stephen J. | - | Buy | 21,053 | $4.75 | $100,001.75 | +126.3% | |
| Nov 30, 2020 | Palmedo Philip F | - | Buy | 21,053 | $4.75 | $100,001.75 | +191.3% | |
| Nov 30, 2020 | Greenberg Robert | - | Buy | 52,632 | $4.75 | $250,002.00 | +5.6% | |
| Nov 30, 2020 | Yen Yun | - | Buy | 52,632 | $4.75 | $250,002.00 | New | |
| Nov 30, 2020 | Schwartzberg Gil | - | Buy | 105,264 | $4.75 | $500,004.00 | +73.9% | |
| Nov 30, 2020 | Ho Hung Tak | - | Buy | 42,105 | $4.75 | $199,998.75 | -100% | |
| Nov 30, 2020 | Kovach John S | President And CEO | Buy | 21,100 | $4.75 | $100,225.00 | +1.4% | |
| Dec 7, 2018 | Palmedo Philip F | Director | Buy | 100,000 | $0.50 | $50,000.00 | +10.0% | |
| Dec 7, 2018 | Forman Stephen J. | Director | Buy | 100,000 | $0.50 | $50,000.00 | New | |
| Dec 7, 2018 | Schwartzberg Gil | 10% Owner | Buy | 1,040,000 | $0.50 | $520,000.00 | +121.6% |